Prof. Michal Vrablik
Michal Vrablik M.D., Ph.D. is currently a Professor of Internal Medicine at the 1st Faculty of Medicine, Charles University in Prague, the Czech Republic. His main interests include preventive cardiology, clinical lipidology, CVD risk reduction strategies with special focus on very high-risk group (e.g. type 2 diabetes), and genetics of lipoprotein metabolism disorders.
He is the chairman of the Czech Atherosclerosis Society, member of board of the Czech Society of Internal Medicine and the chairman of the Czech Association of Preventive Cardiology of the Czech Society of Cardiology. He participates in the FH screening MedPed program being a leader of the project’s national center. He closely cooperates with the International Atherosclerosis Society being the chair of IAS Regional Federation for Europe since January 2019.
Dr. Vrablik has authored and co-authored more than 400 papers in peer-reviewed scientific journals. He is the sole author of three monographs and of 25 book chapters. He is also a member of editorial board as well as a reviewer for several national and international journals.